NAPRT and non-small cell lung carcinoma: Among the remaining non-small cell lung cancer subtypes examined, 20-35 % of cases scored negative for NAPRT expression (0-10 % NAPRT positive) consistent with a previous report scored by IHC from paraffin embedded tissue using a different commercially available antibody [23].